CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | Luly Jay R. President and CEO | Grant or award | +4,800 | 862,826 | ||
| 2026-02-12 | Luly Jay R. President and CEO | Grant or award | +15,200 | 878,026 | ||
| 2026-02-12 | Luly Jay R. President and CEO | Shares withheld for taxes | −6,155 | $14.25 | $88K | 871,871 |
| 2025-12-05 | Luly Jay R. President and CEO | Sale | −4,743 | $14.23 | $67K | 858,026 |
| 2025-12-01 | Luly Jay R. President and CEO | Shares withheld for taxes | −1,885 | $14.12 | $27K | 862,769 |
| 2025-11-25 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +310,000 | 310,000 | ||
| 2025-02-12 | Luly Jay R. President and CEO | Grant or award | +25,500 | 872,138 | ||
| 2025-02-12 | Luly Jay R. President and CEO | Shares withheld for taxes | −7,484 | $5.59 | $42K | 864,654 |
| 2025-02-12 | Luly Jay R. President and CEO | Purchase | +45,000 | $5.69 | $256K | 846,638 |
| 2024-12-06 | Luly Jay R. President and CEO | Sale 10b5-1 | −5,142 | $8.06 | $41K | 801,638 |
| 2024-12-01 | Luly Jay R. President and CEO | Shares withheld for taxes | −3,829 | $8.60 | $33K | 806,780 |
| 2024-11-27 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-02-12 | Luly Jay R. President and CEO | Grant or award | +5,400 | 812,193 | ||
| 2024-02-12 | Luly Jay R. President and CEO | Shares withheld for taxes | −1,584 | $12.41 | $20K | 810,609 |
| 2023-12-05 | Luly Jay R. President and CEO | Sale | −7,230 | $9.63 | $70K | 806,793 |
| 2023-12-01 | Luly Jay R. President and CEO | Shares withheld for taxes | −5,787 | $9.49 | $55K | 814,023 |
| 2023-11-22 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +264,000 | 264,000 | ||
| 2023-03-13 | Luly Jay R. President and CEO | Option exercise | +27,912 | $14.00 | $391K | 847,722 |
| 2023-03-13 | Luly Jay R. President and CEO | Sale | −10,697 | $44.81 | $479K | 837,025 |
| 2023-03-13 | Luly Jay R. President and CEO | Sale | −15,649 | $45.31 | $709K | 821,376 |
Page 1 of 3 · 54 trades